| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 09/01/2005 | DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors |
| 09/01/2005 | DE102004006808A1 Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen Substituted 4,5,6,7-tetrahydro-benzothiazol-2-ylamine compounds |
| 09/01/2005 | CA2555970A1 Therapeutic amide derivatives |
| 09/01/2005 | CA2555963A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 09/01/2005 | CA2555959A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 09/01/2005 | CA2554888A1 Rosiglitazone phosphate and polymorphic forms |
| 09/01/2005 | CA2554774A1 Novel heterocyclic compound |
| 09/01/2005 | CA2554686A1 Compounds |
| 09/01/2005 | CA2554310A1 Benzamide derivatives and their use as glucokinase activating agents |
| 09/01/2005 | CA2537079A1 Fluorene derivative |
| 09/01/2005 | CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 08/31/2005 | EP1568367A1 Compounds effecting glucokinase |
| 08/31/2005 | EP1567525A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 08/31/2005 | EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 08/31/2005 | EP1567501A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
| 08/31/2005 | EP1567494A1 Methods for preparing phenylalkyne derivatives |
| 08/31/2005 | EP1567112A2 Novel chemical compounds |
| 08/31/2005 | EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines |
| 08/31/2005 | EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/31/2005 | CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity |
| 08/31/2005 | CN1662513A 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/31/2005 | CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid |
| 08/31/2005 | CN1662487A Amide linker peroxisome proliferator activated receptor modulators |
| 08/31/2005 | CN1662236A Inhibitors of histone deacetylase |
| 08/31/2005 | CN1662230A Benzoic acid derivatives as modulators of PPAR alpha and gamma |
| 08/31/2005 | CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia |
| 08/31/2005 | CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/30/2005 | US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents |
| 08/30/2005 | US6936638 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 08/30/2005 | US6936630 Sulfur compounds such as 1-(5-chloro-2-methyl-phenyl)-3-(3-methyl-isothiazol-5-yl)-thiourea, used for prophylaxis of cardiovascular disorders |
| 08/30/2005 | US6936629 Compounds and methods for the treatment or prevention of flavivirus infections |
| 08/30/2005 | US6936627 treating/preventing gastrointestinal disorders, inflammations and microbial infections; improving gastroprotective properties of H2 receptor antagonists; decreasing the recurrence of ulcers; facilitating ulcer healing |
| 08/30/2005 | US6936611 Serine protease inhibitors |
| 08/30/2005 | US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 08/25/2005 | WO2005077947A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
| 08/25/2005 | WO2005077945A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 08/25/2005 | WO2005077924A1 Substituted 4,5,6,7-tetrahydro-benzothiazol-2-ylamine compounds |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | WO2005076990A2 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
| 08/25/2005 | WO2005076861A2 Compounds that inhibit hiv particle formation |
| 08/25/2005 | WO2005063724B1 1-(azolin-2-yl) amino-1,2-diphenylethane compounds for combatting insects, arachnids and nematodes |
| 08/25/2005 | WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187271 and for reducing undesirable side effects of antitumor agents |
| 08/25/2005 | US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine |
| 08/25/2005 | US20050187258 Hydrogenation of precursors to thiazolidinedione antihyperglycemics |
| 08/25/2005 | US20050187242 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 08/25/2005 | DE102004005787A1 Carboxamide Carboxamides |
| 08/25/2005 | CA2556084A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
| 08/25/2005 | CA2555595A1 Substituted 4,5,6,7-tetrahydrobenzothiazol-2-ylamine compound |
| 08/25/2005 | CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation |
| 08/24/2005 | EP1565438A1 Antitumor benzoylsulfonamides |
| 08/24/2005 | EP1565428A1 Substituted ureas and carbamates |
| 08/24/2005 | EP1565422A1 Vitamin d receptor modulators |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 08/24/2005 | EP1334085B1 Sulfamides as gamma-secretase inhibitors |
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 08/24/2005 | EP1157014B1 Polycyclic 2-amino-dihydrothiazole systems, method for the production thereof and their utilization as medicament |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | CN1659153A PNA monomer and precursor |
| 08/24/2005 | CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity |
| 08/24/2005 | CN1658872A Antiallergic |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1658855A O-substituted hydroxyaryl derivatives |
| 08/24/2005 | CN1658724A Luminescent element material and luminescent element comprising the same |
| 08/24/2005 | CN1657529A 2-substituted imine thia zlidine derivative its preparation technology and medicinal composition |
| 08/23/2005 | US6933322 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus |
| 08/23/2005 | US6933309 Halogenobenzyl aminopropionic acid derivatives |
| 08/23/2005 | US6933308 Aminoalkyl thiazole derivatives as KCNQ modulators |
| 08/23/2005 | US6933307 Fungicidal phenylimine derivatives |
| 08/18/2005 | WO2005075480A1 Diaza- or thiazadione derivatives with neuroprotective activity |
| 08/18/2005 | WO2005075477A1 Antibacterial compounds |
| 08/18/2005 | WO2005075471A2 Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 08/18/2005 | WO2005075435A1 Modulators of atp-binding cassette transporters |
| 08/18/2005 | WO2005074686A1 N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials |
| 08/18/2005 | WO2005030794A3 Hemiasterlin derivatives and uses thereof |
| 08/18/2005 | US20050182275 Reacting an amino alcohol with oleum to form an aminoalkylsulfate ester, and then further reacting with a mercaptan or salt to form the thioalkylamine in the presence of a diluent and a base; one pot process with increased kinetics |
| 08/18/2005 | US20050182110 tetracylic bridged ring compounds such as 9-nitro-11-amino-11-((imidazol-2-yl)aminocarbonyl)-9,10-dihydro-9,10-ethanoanthracene; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB) |
| 08/18/2005 | US20050182104 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders |
| 08/18/2005 | US20050182096 Haloalkyl containing compounds as cysteine protease inhibitors |
| 08/18/2005 | US20050181443 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| 08/18/2005 | DE10008159B4 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and / or their physiologically acceptable salts as an anti-cancer agent |
| 08/18/2005 | CA2554796A1 Modulators of atp-binding cassette transporters |
| 08/18/2005 | CA2554217A1 Diaza- or thiazadione derivatives with neuroprotective activity |
| 08/17/2005 | EP1564217A2 Process for the production of epothilones |
| 08/17/2005 | EP1562979A2 Tubulysins, method for producing the same and tubulysin preparations |
| 08/17/2005 | EP1562924A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 08/17/2005 | EP1562923A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 08/17/2005 | EP1562921A1 Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole |
| 08/17/2005 | EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 08/17/2005 | EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/17/2005 | EP1562574A1 2-oxo-ethanesulfonamide derivates |
| 08/17/2005 | EP1340750B1 Amide derivatives |
| 08/17/2005 | EP1280757B1 New gamma selective retinoids |
| 08/17/2005 | EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |